Estrogen	estrogen	CHEMICALS	O	OTHERS	I
prevents	prevents	O	O	O	O
cholesteryl	cholesteryl	O	O	OTHERS	I
ester	ester	O	O	OTHERS	I
accumulation	accumulation	O	O	O	O
in	in	O	O	O	O
macrophages	macrophages	O	O	O	O
induced	induced	O	O	O	O
by	by	O	O	O	O
the	the	O	O	O	O
HIV	hiv	CHEMICALS	O	OTHERS	I
protease	protease	CHEMICALS	O	OTHERS	I
inhibitor	inhibitor	CHEMICALS	O	OTHERS	I
ritonavir	ritonavir	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Individuals	individuals	O	O	O	O
with	with	O	O	O	O
HIV	hiv	O	O	O	O
can	can	O	O	O	O
now	now	O	O	O	O
live	live	O	O	O	O
long	long	O	O	O	O
lives	lives	O	O	O	O
with	with	O	O	O	O
drug	drug	O	O	O	O
therapy	therapy	O	O	O	O
that	that	O	O	O	O
often	often	O	O	O	O
includes	includes	O	O	O	O
protease	protease	CHEMICALS	O	OTHERS	I
inhibitors	inhibitors	CHEMICALS	O	OTHERS	I
such	such	O	O	O	O
as	as	O	O	O	O
ritonavir	ritonavir	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Many	many	O	O	O	O
patients	patients	O	O	O	O
,	,	O	O	O	O
however	however	O	O	O	O
,	,	O	O	O	O
develop	develop	O	O	O	O
negative	negative	O	O	O	O
long-term	long-term	O	O	O	O
side	side	O	O	O	O
effects	effects	O	O	O	O
such	such	O	O	O	O
as	as	O	O	O	O
premature	premature	O	O	OTHERS	I
atherosclerosis	atherosclerosis	O	DISEASE	OTHERS	I
.	.	O	O	O	O

We	we	O	O	O	O
have	have	O	O	O	O
previously	previously	O	O	O	O
demonstrated	demonstrated	O	O	O	O
that	that	O	O	O	O
ritonavir	ritonavir	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
increases	increases	O	O	O	O
atherosclerotic	atherosclerotic	O	DISEASE	OTHERS	I
lesion	lesion	O	O	OTHERS	I
formation	formation	O	O	O	O
in	in	O	O	O	O
male	male	O	O	O	O
mice	mice	O	O	O	O
to	to	O	O	O	O
a	a	O	O	O	O
greater	greater	O	O	O	O
extent	extent	O	O	O	O
than	than	O	O	O	O
in	in	O	O	O	O
female	female	O	O	O	O
mice	mice	O	O	O	O
.	.	O	O	O	O

Furthermore	furthermore	O	O	O	O
,	,	O	O	O	O
peripheral	peripheral	O	O	O	O
blood	blood	O	O	O	O
monocytes	monocytes	O	O	O	O
isolated	isolated	O	O	O	O
from	from	O	O	O	O
ritonavir-treated	ritonavir-treated	O	O	O	O
females	females	O	O	O	O
had	had	O	O	O	O
less	less	O	O	O	O
cholesteryl	cholesteryl	O	O	OTHERS	I
ester	ester	O	O	OTHERS	I
accumulation	accumulation	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
the	the	O	O	O	O
present	present	O	O	O	O
study	study	O	O	O	O
,	,	O	O	O	O
we	we	O	O	O	O
have	have	O	O	O	O
investigated	investigated	O	O	O	O
the	the	O	O	O	O
molecular	molecular	O	O	O	O
mechanisms	mechanisms	O	O	O	O
by	by	O	O	O	O
which	which	O	O	O	O
female	female	O	O	O	O
hormones	hormones	O	O	O	O
influence	influence	O	O	O	O
cholesterol	cholesterol	CHEMICALS	O	OTHERS	I
metabolism	metabolism	O	O	O	O
in	in	O	O	O	O
macrophages	macrophages	O	O	O	O
in	in	O	O	O	O
response	response	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
HIV	hiv	CHEMICALS	O	OTHERS	I
protease	protease	CHEMICALS	O	OTHERS	I
inhibitor	inhibitor	CHEMICALS	O	OTHERS	I
ritonavir	ritonavir	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

We	we	O	O	O	O
have	have	O	O	O	O
utilized	utilized	O	O	O	O
the	the	O	O	O	O
human	human	O	O	O	O
monocyte	monocyte	O	O	O	O
cell	cell	O	O	O	O
line	line	O	O	O	O
,	,	O	O	O	O
THP-1	thp-1	O	O	O	O
as	as	O	O	O	O
a	a	O	O	O	O
model	model	O	O	O	O
to	to	O	O	O	O
address	address	O	O	O	O
this	this	O	O	O	O
question	question	O	O	O	O
.	.	O	O	O	O

Briefly	briefly	O	O	O	O
,	,	O	O	O	O
cells	cells	O	O	O	O
were	were	O	O	O	O
differentiated	differentiated	O	O	O	O
for	for	O	O	O	O
72	72	O	O	O	O
h	h	CHEMICALS	O	OTHERS	I
with	with	O	O	O	O
100	100	O	O	O	O
nM	nm	O	O	O	O
PMA	pma	O	O	O	O
to	to	O	O	O	O
obtain	obtain	O	O	O	O
a	a	O	O	O	O
macrophage-like	macrophage-like	O	O	O	O
phenotype	phenotype	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
presence	presence	O	O	O	O
or	or	O	O	O	O
absence	absence	O	O	O	O
of	of	O	O	O	O
1	1	O	O	O	O
nM	nm	O	O	O	O
17beta-estradiol	17beta-estradiol	O	O	O	O
(	(	O	O	O	O
E2	e2	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
,	,	O	O	O	O
100	100	O	O	O	O
nM	nm	O	O	O	O
progesterone	progesterone	CHEMICALS	O	OTHERS	I
or	or	O	O	O	O
vehicle	vehicle	O	O	O	O
(	(	O	O	O	O
0.01	0.01	O	O	O	O
%	%	O	O	O	O
ethanol	ethanol	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
.	.	O	O	O	O

Cells	cells	O	O	O	O
were	were	O	O	O	O
then	then	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
30	30	O	O	O	O
ng/ml	ng/ml	O	O	O	O
ritonavir	ritonavir	CHEMICALS	O	OTHERS	I
or	or	O	O	O	O
vehicle	vehicle	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
presence	presence	O	O	O	O
of	of	O	O	O	O
aggregated	aggregated	O	O	O	O
LDL	ldl	O	O	O	O
for	for	O	O	O	O
24	24	O	O	O	O
h.	h.	O	O	O	O
Cell	cell	CHEMICALS	O	OTHERS	I
extracts	extracts	CHEMICALS	O	OTHERS	I
were	were	O	O	O	O
harvested	harvested	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
lipid	lipid	O	O	O	O
or	or	O	O	O	O
total	total	O	O	O	O
RNA	rna	O	O	O	O
was	was	O	O	O	O
isolated	isolated	O	O	O	O
.	.	O	O	O	O

E2	e2	CHEMICALS	O	OTHERS	I
decreased	decreased	O	O	O	O
the	the	O	O	O	O
accumulation	accumulation	O	O	O	O
of	of	O	O	O	O
cholesteryl	cholesteryl	O	O	OTHERS	I
esters	esters	O	O	OTHERS	I
in	in	O	O	O	O
macrophages	macrophages	O	O	O	O
following	following	O	O	O	O
ritonavir	ritonavir	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
.	.	O	O	O	O

Ritonavir	ritonavir	CHEMICALS	O	OTHERS	I
increased	increased	O	O	O	O
the	the	O	O	O	O
expression	expression	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
scavenger	scavenger	O	O	O	O
receptor	receptor	O	O	O	O
,	,	O	O	O	O
CD36	cd36	O	O	O	O
mRNA	mrna	O	O	O	O
,	,	O	O	O	O
responsible	responsible	O	O	O	O
for	for	O	O	O	O
the	the	O	O	O	O
uptake	uptake	O	O	O	O
of	of	O	O	O	O
LDL	ldl	O	O	O	O
.	.	O	O	O	O

Additionally	additionally	O	O	O	O
,	,	O	O	O	O
ritonavir	ritonavir	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
selectively	selectively	O	O	O	O
increased	increased	O	O	O	O
the	the	O	O	O	O
relative	relative	O	O	O	O
levels	levels	O	O	O	O
of	of	O	O	O	O
PPARgamma	ppargamma	O	O	O	O
mRNA	mrna	O	O	O	O
,	,	O	O	O	O
a	a	O	O	O	O
transcription	transcription	O	O	O	O
factor	factor	O	O	O	O
responsible	responsible	O	O	O	O
for	for	O	O	O	O
the	the	O	O	O	O
regulation	regulation	O	O	O	O
of	of	O	O	O	O
CD36	cd36	O	O	O	O
mRNA	mrna	O	O	O	O
expression	expression	O	O	O	O
.	.	O	O	O	O

Treatment	treatment	O	O	O	O
with	with	O	O	O	O
E2	e2	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
however	however	O	O	O	O
,	,	O	O	O	O
failed	failed	O	O	O	O
to	to	O	O	O	O
prevent	prevent	O	O	O	O
these	these	O	O	O	O
increases	increases	O	O	O	O
at	at	O	O	O	O
the	the	O	O	O	O
mRNA	mrna	O	O	O	O
level	level	O	O	O	O
.	.	O	O	O	O

E2	e2	CHEMICALS	O	OTHERS	I
did	did	O	O	O	O
,	,	O	O	O	O
however	however	O	O	O	O
,	,	O	O	O	O
significantly	significantly	O	O	O	O
suppress	suppress	O	O	O	O
CD36	cd36	O	O	O	O
protein	protein	O	O	O	O
levels	levels	O	O	O	O
as	as	O	O	O	O
measured	measured	O	O	O	O
by	by	O	O	O	O
fluorescent	fluorescent	O	O	O	O
immunocytochemistry	immunocytochemistry	O	O	O	O
.	.	O	O	O	O

This	this	O	O	O	O
data	data	O	O	O	O
suggests	suggests	O	O	O	O
that	that	O	O	O	O
E2	e2	CHEMICALS	O	OTHERS	I
modifies	modifies	O	O	O	O
the	the	O	O	O	O
expression	expression	O	O	O	O
of	of	O	O	O	O
CD36	cd36	O	O	O	O
at	at	O	O	O	O
the	the	O	O	O	O
level	level	O	O	O	O
of	of	O	O	O	O
protein	protein	O	O	O	O
expression	expression	O	O	O	O
in	in	O	O	O	O
monocyte-derived	monocyte-derived	O	O	O	O
macrophages	macrophages	O	O	O	O
resulting	resulting	O	O	O	O
in	in	O	O	O	O
reduced	reduced	O	O	O	O
cholesteryl	cholesteryl	O	O	OTHERS	I
ester	ester	O	O	OTHERS	I
accumulation	accumulation	O	O	O	O
following	following	O	O	O	O
ritonavir	ritonavir	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
.	.	O	O	O	O

